Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?

Biogerontology

Volumn 16, Issue 1, 2015, Pages 15-29

  Kob, Robert ^a   Bollheimer, L Cornelius ^a,b   Bertsch, Thomas ^c   Fellner, Claudia ^d   Djukic, Marija ^e,f   Sieber, Cornel C ^a,b   Fischer, Barbara E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Oncology and Hematology   (Germany)

^c Paracelsus Medical University   (Germany)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^e Sleep Laboratory   (Germany)

^f UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Inflamm aging; Lipotoxicity; Metabolism; Sarcopenic obesity

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FATTY ACID; FATTY ACID DERIVATIVE; GROWTH HORMONE; INTERLEUKIN 6; LIPID; MYOSTATIN; OXYTOCIN; TESTOSTERONE;

ADIPOCYTE; AEROBIC EXERCISE; APOPTOSIS; BODY MASS; CATABOLISM; CELL DIFFERENTIATION; CELL RENEWAL; ENERGY CONSERVATION; ENERGY RESOURCE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFLAMMATION; INSULIN RESISTANCE; LIPID STORAGE; LIPOTOXICITY; MOLECULAR PATHOLOGY; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE LEVEL; MUSCLE MASS; MUSCLE REGENERATION; MUSCLE STEM CELL; NONHUMAN; NUTRITIONAL STATUS; OXIDATIVE STRESS; PARACRINE SIGNALING; PHENOTYPE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RESISTANCE TRAINING; REVIEW; SARCOPENIC OBESITY; SKELETAL MUSCLE; AGING; MUSCLE WEAKNESS; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SARCOPENIA; SIGNAL TRANSDUCTION;

AGING; HUMANS; INSULIN RESISTANCE; MUSCLE WEAKNESS; MUSCLE, SKELETAL; OBESITY; SARCOPENIA; SIGNAL TRANSDUCTION;

EID: 84922074212     PISSN: 13895729     EISSN: 15736768     Source Type: Journal    
DOI: 10.1007/s10522-014-9539-7     Document Type: Review

References (121)

1. Adams JM, Pratipanawatr T, Berria R, Wand E, DeFronzo RA, Sullards MC, Mandarino LJ (2004) Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53:25–31
2. Allan CA, Strauss BJG, McLachlan RI (2007) Body composition, metabolic syndrome and testosterone in ageing men. Int J Impot Res 19:448–457
3. Allen DL, Hittel DS, Mcpherron AC (2011) Expression and function of myostatin in obesity, diabetes, and exercise adaptation. Med Sci Sports Exerc 43:1828–1835
4. Anderson R, Prolla T (2009) PGC 1 alpha in aging and anti-aging interventions. Biochim Biophys Acta 1790:1059–1066
5. Argiles JM, Orpi M, Busquets S, Lopez-Sorian F (2012) Myostatin: more than just a regulator of muscle mass. Drug Discov Today 17:702–709
6. Ballak DB, Van Essen P, Van Diepen JA, Jansen H, Hijams A, Matsuguchi T, Sparrer H, Tack CJ, Netea MG, Joosten LAB, Stienstra R (2014) MAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and mice. PLOS ONE 9
7. Batsis JA, Barre LK, Mackenzie TA, Pratt SI, Lopez-Jimenez F, Bartels SJ (2013) Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy x-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999–2004. J Am Geriatr Soc 61:974–980
8. Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ (2014) Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr 68:1001–1007
9. Baumgartner RN (2000) Body composition in healthy aging. Ann N Y Acad Sci 904:437–448
10. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE (2004) Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 12:1995–2004
11. Boldrin L, Muntoni F, Morgan JE (2010) Are human and mouse satellite cells really the same? J Histochem Cytochem 58:941–955
12. Bollheimer LC, Buettner R, Pongratz G, Brunner-Ploss R, Hechtl C, Banas M et al (2012) Sarcopenia in the aging high-fat fed rat: a pilot study for modeling sarcopenic obesity in rodents. Biogerontology 13:609–620
13. Bouchard DR, Dionne IJ, Brochu M (2009) Sarcopenic/obesity and physical capacity in older men and women: data from the nutrition as a determinant of successful aging (NuAge)—the Quebec Longitudinal Study. Obesity 17:2082–2088
14. Bouchonville MF, Villareal DT (2013) Sarcopenic obesity: how do we treat is? Endocrinology 20:412–419
15. Boudou P, Sobngwi F, Mauvais-Jarvis P, Vexiau P, Gautier JF (2003) Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men. Eur J Endocrin 149:421–424
16. Boutcher SH (2011) High-intensity intermittent exercise and fat loss. J Obes. doi:10.1155/2011/868305
17. Cai D, Frantz JD, Tawa NE Jr et al (2004) IKKβ/NF-κB activation causes severe muscle wasting in mice. Cell 119:285–298. doi:10.1016/j.cell.2004.09.027
18. Camerino C (2009) Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity 17:980–984
19. Carbó N, Busquets S, van Royen M, Alvarez B, Lopez-Soriano FJ, Argiles JM (2002) TNF-alpha is involved in activating DNA fragmentation in skeletal muscle. Br J Cancer 86:1012–1016. doi:10.1038/sj.bjc.6600167
20. Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BW, Lenchik L et al (2005) Sarcopenia, obesity, and inflammation—results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study. Am J Clin Nutr 8(82):428–434
21. Chen MB, McAinch AJ, Macaulay SL, Castelli LA, O’brien PE, Dixon JB, Cameron-Smith D, Kemp BE, Steinberg GR (2005) Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab 90:3665–3672
22. Chia DJ, Ono M, Woelfle J, Schlesinger-Massart M, Jiang H, Rotwein P (2006) Characterization of distinct Stat5b binding sites that mediate growth hormone-stimulated IGF-I gene transcription. J Biol Chem 281:3190–3197
23. Choi CS, Befroy DE, Codella R, Kim S, Reznick RM, Hwang YJ, Liu ZX, Lee HY, Distefano A, Samuel VT, Zhang D, Cline GW, Handschin C, Lin J, Petersen KF, Spiegelman BM, Shulman GI (2008) Paradoxical effects of increased expression of PGC-1 alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism. Proc Nat Acad Sci 105:19926–19931
24. Ciciliot S, Schiaffino S (2010) Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications. Curr Pharm Des 16:906–914
25. Consitt LA, Bell JA, Houmard JA (2009) Intramuscular lipid metabolism, insulin action and obesity. IUBMB Life 61:47–55
26. Cooper R, Kuh D, Cooper C, Gale CR, Lawlor DA, Matthews F, Hardy R, The FALCon and HALCyon Study Teams (2011) Objective measures of physical capability and subsequent health: a systematic review. Age Ageing 40:4–23
27. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis. Age Ageing 39:412–423
28. Deblon N, Veyrat-Durebex C, Bourgoin L, Caillon AK, Bussier A-L, Petrosino S, Piscitelli F, Legros J-J, Geenen V, Foti M, Wahli W, Di Marzo V, Rohner-Jeanrenaud F (2011) Mechanisms of the ant-obesity effects of oxytocin in diet-induced obese rats. PLoS ONE 6:e25565
29. Derbré F, Gomez-Cabrera MC, Nascimento AL, Sanchis-Gomar F, Martinez-Bello VE, Tresguerres JAF et al (2012) Age associated low mitochondrial biogenesis may be explained by lack of response of PGC-1α to exercise training. AGE 34:669–679
30. Doak CM, Wijnhoven TMA, Schokker DF, Visscher TLS, Seidell JC (2012) Age standardization in mapping adult overweight and obesity trends in the WHO European Region. Obes Rev 13:174–191
31. Donges CE, Duffield R, Drinkwater EJ (2010) Effects of resistance or aerobic exercise training on interleukin-6, C-reactive protein, and body composition. Med Sci Sports Exerc 42:304–313
32. Donnelly JE, Blair S, Jakicic J, Manore M, Rankin J, Smith B (2009) American college of sports medicine position stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 41:459–471
33. Elabd C, Cousin W, Upadhyayula P, Chen RY, Chooljian MS, Li J, Kung S, Jiang KP, Conboy IM (2014) Oxytocin is an age-specific circulation hormone that is necessary for muscle maintenance and regeneration. Nat Commun 5:4082/doi: 10.1038/ncomms5082
34. Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, et al (2008) Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 299:3952
35. Espinoza DO, Boros LG, Crunkhorn S, Gami H, Patti ME (2010) Dual modulation of both lipid oxidation and synthesis by peroxisome proliferator-activated receptor-gamma coactivator -1alpha and -1beta in cultured myotubes. FASEB 24:1003–1014
36. Fellner C, Schick F, Kob R, Hecht C, Vorbuchner M, Büttner R, Hamer OW, Sieber CC, Stroszczynski C, Bollheimer LC (2014) Diet-induced and age-related changes in the quadriceps muscle: MRI and MRS in a rat model of sarcopenia. Gerontology. doi:10.1159/000360289
37. Fiatarone MA, Marks EC, Ryan ND, Meredith CN, Lipsitz LA, Evans WJ (1990) High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA 263:3029–3034
38. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology and consequences. J Am Med Dir Assoc 12:249–256
39. Florez H, Troen BR (2008) Fat and inflammaging: a dual path to unfitness in elderly people? J Am Geriatr Soc 56:558–560
40. Florini JR, Ewton DZ, Coolican SA (1996) Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17:481–517
41. Frimel TN, Dinacore DR, Villarreal T (2008) Exercise attenuates the weight-loss-induced reduction in muscle mass in frail obese older adults. Med Sci Sports Exerc 40:1213–1219
42. Frontera WR, Meredith CN, O’Reilly KP, Knuttgen HG, Evans WJ (1988) Strength conditioning in older men: skeletal muscle hypertrophy and improved function. J Appl Physiol 64:1038–1044
43. Fujita S, Rasmussen BB, Cadenas JG, Drummond MJ, Glynn EL, Sattler FR, Volpi E (2007) Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt/mammalian target of rapamycin signaling. Diabetes 56:1615–1622
44. Garris D (2005) Cytochemical analysis of pancreatic islet lipoapoptosis: hyperlipidemia-induced cytoinvolution following expression of the diabete (db/db) mutation. Pathobiology 72:124–132
45. Goodpaster BH, He J, Watkins S, Kelley DE (2001) Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86:5755–5761
46. Griffin ME, Marcucci MJ, Clone GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase c theta and alteration in the insulin signaling cascade. Diabetes 48:1270–1274
47. Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Geront 11:298–300
48. Herbst A, Pak JW, McKenzie D, Bua E, Bassiouni M, Aiken JM (2007) Accumulation of mitochondrial DNA mutations in aged muscle fibers: evidence for a causal role in muscle fiber loss. J Geront A Biol Sci Med Sci 62:235–245
49. Hittel DS, Berggren JR, Shearer J, Boyle K, Houmard JA (2009) Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes 58:30–38
50. Iossa S, Lionetti L, Mollica MP, Crescenzo R, Barletta A, Liverini G (2001) Fat balance and serum leptin concentrations in normal, hypothyroid, and hyperthyroid rats. Int J Obes Relat Metab Disord J Int Assoc Study Obes 25:417–425
51. Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, Häring HU (1999) Association of increased intramyocellular lipid contend with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 42:1113–1119
52. Kadi F, Ponsol E (2010) The biology of satellite cells and telomeres in human skeletal muscle: effects of aging and physical activity. Scan J Med Sci Sports 20:39–48
53. Kennedy RL, Chokkalingham K, Srinivasan R (2004) Obesity in the elderly: who should we be treating, and why, and how? Curr Opin Clin Nutr Metab Care 7:3–9
54. Kohut ML, McCann DA, Russell DW, Konopka DN, Cunnick JE, Franke WD et al (2006) Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of β-blockers, BMI, and psychosocial factors in older adults. Brain Behav Immun 20:201–209
55. Kok P, Roelfsema F, Langendonk JG, Frölich M, Burggraaf J, Meinders AE et al (2005) High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. J Clin Endocrinol Metab 90:4659–4663
56. Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, Rothman DL, Roden M, Shulman GI (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42:113–116
57. Kusminski CM, Shetty S, Orci L, Unger RH, Scherer PE (2009) Diabetes and apoptosis: lipotoxicity. Apoptosis 14:1484–1495
58. La Cava A, Matarese G (2004) The weight of leptin in immunity. Nature Rev Immunol 4:371–379
59. Lambert CP, Wright NR, Finck BN, Villareal DT (2008) Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly persons. J Appl Physiol 105:473–478
60. Landi F, Cruz-Jentoft AJ, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, Bernabei R, Graziano O (2013) Sarcopenia and mortality risk in frail older persons aged 80 years and older: result from ilSIRENTE study. Age Ageing 42:203–209
61. Lanning NJ, Carter-Su C (2006) Recent advances in growth hormone signaling. Rev Endocr Metab Disord 7:225–235
62. Lanza IR, Nair KS (2009) Muscle mitochondrial changes with aging and exercise (2009) Muscle mitochondrial changes with aging and exercise. Am J Clin Nutr 89:467S–471S
63. Latham N, Anderson C, Bennet D, Stretton C (2003) Progressive resistance strength training for physical disability in older people. Cochrane Database Syst Rev 2:CD002759
64. LeBrasseur NK (2012) Building muscle, browning fat and preventing obesity by inhibiting myostatin. Diabetologia 55:13–17
65. Lee S-J (2004) Regulation of muscle mass by myostatin. Ann Rev Cell Dev Biol 20:61–86
66. Levine ME, Crimmins EM (2012) The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning. Obesity 20:2101–2106
67. Magnuson B, Ekim B, Fingar DC (2012) Regulation and function of ribosomal protein S6 kinase (S6 K) within mTOR signaling networks. Biochem J 441:1–21
68. Marzetti E, Carter CS, Wohlgemuth SE, Lees HA, Giovannini S, Anderson B et al (2009) Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction. Mech Ageing Dev 130:272–280
69. Marzetti E, Hwang JC, Less HA, Wohlgemuth SE, Dupont-Versteegden EE, Carter CS, Benabei R, Leeuwenburgh C (2010) Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophy. Biochim Biophys Acta 1800:235–244
70. Mathus-Vliegen EMH, on behalf of the Obesity Management Task Force (OMTF) of the European Association for the Study of Obesity (EASO) (2012) Prevalence, pathophysiology, health consequences and treatment of obesity in the elderly: a guideline. Obes Facts 5:460–483
71. Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, Gearon KC, Laviano A, Maggio M, Rossi Fanelli F, Schneider SM, Schols A, Sieber CC (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) Cachexia-anorexia in chronic wasting diseases and nutrition in geriatrics. Clin Nutr 29:154–159
72. Nicklas BJ, Hsu F-C, Brinkley TJ, Church T, Goodpaster BH, Kritchevsky SB et al (2008) Exercise training and plasma C-reactive protein and interleukin-6 in the elderly. J Am Geriatr Soc 56:2045–2052
73. Nilsson MI, Dobson JP, Greene NP, Wiggs MP, Shimkus KL, Wudeck EV et al (2013) Abnormal protein turnover and anabolic resistance to exercise in sarcopenic obesity. FASEB J. doi:10.1096/fj.12-224006
74. Pedersen BK, Febbraio MA (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88:1379–1406
75. Pratesi A, Tarantini F, Di Bari M (2013) Skeletal muscle: an endocrine organ. Clin Cases Miner Bone Metab 10:11–14
76. Quinn LS, Anderson BG, Drivdahl RH, Alvarez B, Argilés JM (2002) Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders. Exp Cell Res 280:55–63
77. Reznick RM, Zhong H, Li J, Morino K, Moore IK, Yu HJ, Liu ZX, Dong J, Mustard KJ, Hawley SA, Befroy D, Pypaert M, Hardie DG, Young LH, Shulman GI (2007) Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell 5:151–156
78. Rolland Y, Lauwers-Cances V, Cristini C, van Kan GA, Janssen I, Morley JE et al (2009) Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l’OSteoporose) Study. Am J Clin Nutr 89:1895–1900
79. Roubenoff R (2003) Catabolism of aging: is it an inflammatory process? Curr Opin Clin Nutr Metab Care 6:295–299
80. Ryall JG, Schertzer JD, Lynch GS (2008) Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology 9:213–228
81. Sainsbury A, Zhang L (2012) Role of the hypothalamus in the neuroendocrine regulation of body weight and composition during energy deficit. Obes Rev 13:234–257
82. Sakuma K, and Yamaguchi A (2013) Sarcopenic obesity and endocrinal adaptation with age. Int J Endocrinol 204164. doi: 10.1155/2013/204164
83. Sakuma K, Watanabe K, Hotta N, Koike T, Ishida K, Katayama K, Akima H (2009) The adaptive responses in several mediators linked with hypertrophy and atrophy of skeletal muscle after lower limb unloading in humans. Acta Physiol 197:151–159
84. Sakuma K, Aoi W, Yamaguchi A (2014) Current understanding of sarcopenia: possible candidates modulating muscle mass. Pflugers Arch—Eur J Physiol 1–17
85. Schaap LA, Pluijm SMF, Deeg DJH, Visser M (2006) Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 119:526.e9–526.e1
86. Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, Ferrucci L (2007) Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 102:919–925
87. Sepe A, Tchkonia T, Thomou T, Zamboni M, Kirkland JL (2011) Aging and regional differences in fat cell progenitors—a mini-review. Gerontology 57:66–75
88. Shimabukuro M, Zhou Y-T, Levi M, Unger RH (1998) Fatty acid-induced β cell apoptosis: a link between obesity and diabetes. Proc Nat Acad Sci USA 95:2498–2502
89. Sparangna G, Hickson-bick D (2000) A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol 279:H2124–H2132
90. Stenholm S, Harris TB, Rantanen MS, Visser M, Kritchevsky SB, Ferrucci L (2008a) Sarcopenic obesity—definition, etiology and consequences. Curr Opin Clin Nutr Metab Care 11:693–700
91. Stenholm S, Rantanen T, Heliövaara M, Koskinen S (2008b) The mediating role of c-reactive protein and handgrip strength between obesity and walking limitation. J Am Geriatr Soc 56:462–469
92. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jäger S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivator. Cell 20:397–408
93. Summermatter S, Thurnheer R, Santos G, Mosca B, Baum O, Treves S et al (2012) Remodeling of calcium handling in skeletal muscle through PGC-1α: impact on force, fatigability, and fiber type. Am J Physiol—Cell Physiol 302:C88–C99
94. Summers SA (2006) Ceramide in insulin resistance and lipotoxicity. Progr Lipid Res 45:42–72
95. Takayanagi Y, Kasahara Y, Onaka T, Takahashi N, Kaeada T, Nishimori K (2008) Oxytocin receptor-deficient mice developed late-onset obesity. NeuroReport 19:951–955
96. Tapp EG, Chisholm DJ, Freund J, Boutcher SH (2008) The effects of high-intensity intermittent exercise training on fat loss and fasting insulin levels of young women. Int J Obes 32:684–691
97. Thornell LE (2011) Sarcopenic obesity: satellite cells in the aging muscle. Curr Opin Clin Nutr Metab Care 14:22–27
98. Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6:772–783
99. Timmerman KL, Dhanani S, Glynn EL, Fry CS, Drummond MJ, Jennins K, Rasmussen BB, Volpi E (2012) A moderate acute increase in physical activity enhances nutritive flow and the muscle protein anabolic response to mixed nutrient intake in older adults. Am J Clin Nutr 95:1403–1412
100. Turpin SM, Ryall JG, Southgate R, Darby I, Hevener AL, Febbraio MA et al (2009) Examination of lipotoxicity’ in skeletal muscle of high-fat fed and ob/ob mice. J Physiol 587:1593–1605
101. Urban RJ, Bodenburg YH, Gilkison C, Foxworth J, Coggan AR, Wolfe RR, Ferrando A (1995) Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 32:E820–E826
102. Van Herpen NA, Schrauwen-Hinderling VB (2008) Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 94:231–241
103. Vilarrasa N, Vendrell J, Maravall J, Broch M, Estepa A, Begia A, Soler J, Simon I, Richart C, Gomez JM (2005) Distribution and determinants of adiponectin, resistin and ghrelin in a randomly selected healthy population. Clin Endocrinol 63:329–335
104. Villareal DT, Smith GI, Sinacore DR, Shah K, Mittendorfer B (2011) Regular multi-component exercise increases physical fitness and muscle protein anabolism in frail, obese, older adults. Obesity 19:312–318
105. Volkert D (2013) Malnutrition in older adults-urgent need for action: a plea for improving the nutritional situation of older adults. Gerontology 59:328–333
106. Volkert D, Sieber CC (2011) Protein requirements in the elderly. Int J Vitam Nutr Res 81:109–119
107. Walker DK, Dickinson JM, Timmerman KL, Drummond MJ, Reidy PT, Fry CA, Gundermann DM, Rasmussen BB (2011) Exercise, amino acids and aging in the control of human muscle protein synthesis. Med Sci Sports Exerc 43:2249–2258
108. Waters DL, Baumgartner RN, Garry PJ, Vellas B (2010) Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging 5:259–270
109. Watt MJ, Hebvener A, Lancaster GI, Febbraio MJ (2006) CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat Med 12:541–548
110. Wei Y, Wand D, Topczewski F, Pagliassotti MJ (2006) Saturated fatty acids induce endoplasmatic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab 291:E275–E281
111. Wende AR, Schaeffler PJ, Parker GJ, Zechner C, Han DH, Chen MM, Hancook CR, Lehmann JJ, Huss JM, McClain DA, Hollszy JO, Kelly DP (2007) A role for the transcriptional coactivator PGC-1 alpha in muscle refueling. J Biol Chem 282:36642–36651
112. Wenz T, Rossi SG, Rotundo RG, Spiegelman BM, Moraes CT (2009) Increased muscle PGC-1α expression protects from sarcopenia and metabolic disease during aging. Proc Nat Acad Sci USA 106:20405–20410
113. White TA, LeBrasseur NK (2014) Myostatin and sarcopenia: opportunities and challenges—a mini-review. Gerontology 60:289–293
114. Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, Tjonna AE, Helgerud J, Slordahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen O, Skjaerpe T (2007) Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients. A randomized study. Circulation 115:3086–3094
115. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Ananuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T (2002) Adiponectin stimulates glucose utilization and fatty acid oxidation by activating AMP-activated protein kinase. Nat Med 11:1288–1295
116. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekaea S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762–769
117. Yarasheski KE, Bhasin S, Sinha-Hikim I, Pak-Loduca J, Gonzalez-Cadavid NF (2002) Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J Nutr Health Aging 6:343–348
118. Yeap BB, Paul Chubb SA, Lopez D, Ho KKY, Hankey GJ, Flicker L (2012) Associations of insulin-like growth factor-I and its binding proteins, and testosterone, with frailty in older men. Clin Endocrinol 78:752–759
119. Zamboni M, Mazzali G, Zoico E, Harris TB, Meigs JB, Di Franchesco V, Fantin F, Bissoli L, Bosello O (2005) Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes 29:1011–1029
120. Zamboni M, Mazzali G, Fantin F, Rossi A, Di Franchesco V (2008) Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis 18:388–395
121. Zhang G, Bai H, Zhang H, Dean C, Wu Q, Li J, Guariglia S, Meng Q, Cai D (2011) Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance. Neuron 69:523–535